Molecular characterization of HBB gene mutations in beta-thalassemia patients of Southern Iraq
Keywords:beta-thalassemia, mutation, PCR
Introduction and Aim: Beta-thalassemia is a serious inherited genetic disorder and an increasing health burden globally. Beta -thalassemia is caused by genetic globin abnormalities within the hemoglobin beta (HBB) gene. This study aimed to characterize the HBB gene mutations in beta -thalassemia among southern Iraqi patients.
Materials and Methods: The study included 30 beta -thalassemia patients referred to the Thi-Qar Center for Genetic Diseases, Iraq and 15 control samples from a random group of apparently healthy individuals. Genomic DNA was isolated from blood sample collected from each individual. The DNA was amplified for specific regions of the HBB gene and the amplified products sequenced. The sequences generated were analysed for mutations using sequence analysis tools.
Results: Molecular analysis revealed several mutations in the HBB gene including translocation, deletion and substitution mutations in the population tested positive for the beta -thalassemia trait.
Conclusion: Thalassemia major is a serious concern in southern Iraq and therefore this study emphasizes a need for complete mutation profiling of the beta -globin gene as a strategy for screening of carriers within the population. Such examinations could be useful in pre-marital genetic counseling and for undertaking prevention and treatment measures.
Saleh, K.K.,Kakey, E.S. Some molecular characterization of beta-thalassemia major in Koya City. In International Conference on Pure and Applied Sciences.2018; 4(1):64-68. DOI: https://doi.org/10.14500/icpas2018.bph25
Galanello, R. Origa, R. Beta Thalassemia. Orphanet journal of rare diseases, 2010; 5(1):1-15. DOI: https://doi.org/10.1186/1750-1172-5-11
Chaudhary, S., Dhawan, D., Sojitra, N., Chauhan, P., Chandratre, K., Chaudhary, P.S., 2017. Whole gene sequencing based screening approach to detect beta-thalassemia mutations. Biol Med (Aligarh), 2017, 9(383):2. DOI: https://doi.org/10.4172/0974-8369.1000383
Mandal, P.K., Maji, S.K. and Dolai, T.K. Present scenario of hemoglobinopathies in West Bengal, India: An analysis of a large population. International Journal of Medicine and Public Health,2014; 4(4):496. DOI: https://doi.org/10.4103/2230-8598.144127
Higgs, D.R., Engel, J.D., Stamatoyannopoulos, G. Thalassaemia. The lancet. 2012;379 (9813): 373-383. DOI: https://doi.org/10.1016/S0140-6736(11)60283-3
Hamed, E.A., ElMelegy, N.T. Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Italian journal of pediatrics,2010; 36(1):1-10. DOI: https://doi.org/10.1186/1824-7288-36-39
Mashi, A., Khogeer, H., Abalkhail, H., Khalil, S. Molecular patterns of beta-thalassemia mutations of Saudi patients referred to King Faisal Specialist Hospital and Research Center. Journal of Applied Hematology, 2017;8(3):99-104. DOI: https://doi.org/10.4103/joah.joah_61_16
Cao, A. Galanello, R. Beta-thalassemia. Genet Med, 2010; 12(2):61-76. DOI: https://doi.org/10.1097/GIM.0b013e3181cd68ed
Aziz, A., Ahmed, W., Sarwardi, G., Ara Naznin, R., Rehena, J., Ferdoushi, A. Molecular Analysis of Hb-E and Beta-Thalassemia Major Patients among Bangladeshi Population. Austin J Biotechnol Bioeng, 2017; 4(4):1085.
Vichinsky, E.P. Changing patterns of thalassemia worldwide. Annals of the New York Academy of Sciences, 2005;1054(1):18-24. DOI: https://doi.org/10.1196/annals.1345.003
Al-Allawi, N.A., Jalal, S.D., Ahmed, N.H., Faraj, A.H., Shalli, A.,Hamamy, H. The first five years of a preventive programme for haemoglobinopathies in Northeastern Iraq. Journal of Medical Screening, 2013; 20(4):171-176. DOI: https://doi.org/10.1177/0969141313508105
Al-Allawi, N.A., Jalal, S.D., Nerwey, F.F., Al-Sayan, G.O., Al-Zebari, S.S., Alshingaly, A.A., et al. Sickle cell disease in the Kurdish population of northern Iraq. Hemoglobin, 2012; 36(4):333-342. DOI: https://doi.org/10.3109/03630269.2012.692344
Kazazian HH, Antonarakis SE. The varieties of mutation Prog Med Genet. 1988; 7:43- 67.
Warsy AS, ElHazmi MA, Al Momin AK, et al. Extensive polymorphisms in Saudi beta thalassaemia patients. Biosci Biotechnol Res Asia. 2013;10: 127-132. DOI: https://doi.org/10.13005/bbra/1103
Ahmed, A.A., Khaleel, K.J., Fadhel, A.A., Al-Rubaii, B.A.L. Chronic Myeloid Leukemia: A retrospective study of clinical and pathological features. Bionatura, 2022, 7(3), 41. DOI. 10.21931/RB/2022.07.03.41. DOI: https://doi.org/10.21931/RB/2022.07.03.41
Ali, S.M., Lafta, B.A., Al-Shammary, A.M., Salih, H.S. In vivo oncolytic activity of non-virulent newcastle disease virus Iraqi strain against mouse mammary adenocarcinoma. AIP Conference Proceedings, 2021, 2372, 030010. DOI: https://doi.org/10.1063/5.0067194
Awadh, H.A., Hammed, Z.N., Hamzah, S.S., Saleh, T.H., Al-Rubaii, B.A.L. Molecular identification of intracellular survival related Brucella melitensis virulence factors. Biomedicine (India), 2022, 42(4):761–765. DOI: https://doi.org/10.51248/.v42i4.1642
Fakhry, S.S., Hammed, Z.N., Bakir, W.A.-E., ALRubaii, B.A.L. Identification of methicillin-resistant strains of Staphylococcus aureus isolated from humans and food sources by use mecA 1 and mecA 2 genes in Pulsed-field gel electrophoresis technique, 2022, 7(2):44. DOI. 10.21931/RB/2022.07.02.44. DOI: https://doi.org/10.21931/RB/2022.07.02.44
Jiad, A.L., Ismael, M.K., Salih, T.A., Malik, S.N., Al-Rubaii, B.A.L. Genotyping and evaluation of interleukin-10 and soluble HLA-G in abortion due to toxoplasmosis and HSV-2 infections. Annals of parasitology. 2022, 68(2):385–390.
Hashim, S.T., Fakhry, S.S., Rasoul, L.M., Saleh, T.H., Alrubaii, B.A.L. Genotyping toxins of Clostridium perfringens strains of rabbit and other animal origins. Tropical Journal of Natural Product Researchthis link is disabled, 2021, 5(4): 613–616. DOI: https://doi.org/10.26538/tjnpr/v5i4.3
How to Cite
Copyright (c) 2022 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.